Montelukast Gemax Pharma

Montelukast, the active ingredient in Montelukast Gemax Pharma, is a leukotriene receptor antagonist presented as an unknown/unknown for oral use. It is used to manage asthma, allergic rhinitis and exercise‑induced bronchoconstriction in both adults and children.

GNH USA supplies Montelukast Gemax Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare institutions worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution, ensuring product integrity throughout the supply chain.

Montelukast acts on the cysteinyl leukotriene pathway to manage respiratory and allergic conditions.

Asthma: provides maintenance therapy that reduces bronchoconstriction and airway inflammation. Allergic rhinitis: alleviates nasal congestion, sneezing and itching. Exercise‑induced bronchoconstriction: prevents airway narrowing triggered by physical activity.

Montelukast may cause a range of adverse reactions, which are classified by frequency.

Common Side Effects: - Headache - Abdominal pain - Cough - Nausea

Serious or Rare Side Effects: - Allergic reactions (rash, angioedema) - Mood changes (depression, suicidal thoughts) - Elevated liver enzymes

When prescribing Montelukast, consider the following precautions.

Assess asthma control before initiating therapy: ensure patient is on appropriate baseline treatment. Monitor for neuropsychiatric symptoms: watch for mood changes or depression. Review concomitant medications: consider potential interactions. Use caution in hepatic impairment: adjust if needed. Store at room temperature: keep in original packaging, protect from moisture.

Montelukast can interact with other medicines; review the following categories.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may increase montelukast exposure. - Phenobarbital or other enzyme inducers: may reduce montelukast effectiveness.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline): monitor for neuropsychiatric effects. - Theophylline: observe for additive bronchodilation. - Warfarin: monitor INR for potential changes.